- American Psychiatric
Association. Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition. Washington DC: American Psychiatric Association, 1994.
- Belanoff JK,
Flores BH, Kalezhan M, et al. Rapid reversal of psychotic depression
using mifepristone. J Clin Psychopharmacol 2001;21:516-21.
- Belanoff JK,
Gross K, Yager A, et al. Corticosteroids and cognition. J Psychiatr
Res 2001;35:127-45.
- Belanoff JK,
Kalezhan M, Sund B, et al. Cortisol activity and cognitive changes
in psychotic major depression. Am J Psychiatry 2001;158:1612-16.
- Belanoff JK,
Rothschild AJ, Cassidy F, DeBattista C, Baulieu E, Schold C, Schatzberg
A. An Open Label Trial of C-1073 (Mifepristone) for Psychotic Major
Depression. Biol Psychiatry 2002;52:386-392.
- Chu JW, Matthias
DF, Belanoff J, et al. Successful long-term treatment of refractory
Cushing's Disease with high-dose mifepristone (RU 486). J Clin Endocrinol
Metab 2001; Aug;86(8):3568-73.
- Commentary. New
Insights into the Role of Cortisol and the Glucocorticoid Receptor
in Severe Depression. Biol Psychiatry 2002;52:381-385.
- Coryell W, Pfohl
B, Zimmerman M. The clinical and neuroendocrine features of psychotic
depression. J Nerv Ment Dis 1984;172:521-28.
- Coryell W. Psychotic
depression. J Clin Psychiatry 1996;57 Suppl 3:27-31.
- Dubovsky SL,
Thomas M. Psychotic Depression: Advances in conceptualization and
treatment. Hosp Community Psychiatry 1992;43:1189-98.
- Frasure-Smith
N, Lesperance F, Talajic M. Depression and 18-month prognosis after
myocardial infarction. Circulation, 1995; 91(4): 999-1005.
- Kahn, et al.
Symptom Reduction and Suicide Risk in Patients Treated with Placebo
in Antidepressant Clinical Trials. Arch Gen Psychiatry, 2000; 57:311-317.
- Leyton M, Corin
E, Martial J, et al. Psychotic symptoms and vulnerability to recurrent
major depression. J Affect Disord 1995;33(2):107-15.
- Murphy SL. Deaths:
final data for 1998. National Vital Statistics Report, 48(11). DHHS
Publication No. 2000-1120. Hyattsville, MD: National Center for Health
Statistics, 2000.
- Murray CJL, Lopez
AD eds. The Global Burden of Disease, Harvard School of Public Health,
World Bank, World Health Organization, 1996.
- National Comorbidity
Survey.
- National Institute
of Mental Health (NIMH). Fact Sheet: Co-Occurrence of Depression with
Heart Disease. Bethesda, MD: 1999.
- Ohayon, MM and
Schatzberg. Prevalence of Depressive Episodes With Psychotic Features
in the General Population. Am J Psychiatry, 2002; 159: 1855-1861.
- Olfson M, Marcus
S, Sackeim HA, et al. Use of ECT for the inpatient treatment of recurrent
major depression. Am J Psychiatry 1998:155:22-29.
- Pratt LA, Ford
DE, Crum RM, et al. Depression, psychotropic medication, and risk
of myocardial infarction. Prospective data from the Baltimore ECA
follow-up. Circulation, 1996; 94(12): 3123-9.
- Roose SP, Glassman
AH, Walsh BT, et al. Depression, Delusions, and Suicide. Am J Psychiatry
1983;140:1159-62.
- Roose, et al.
Depression, Delusions, and Suicide. Am J Psychiatry, 2000; 57:1159-1162.
- Schatzberg AF,
Rothschild AJ, Langlais PJ, et al. A corticosteroid/dopamine hypothesis
for psychotic depression and related states. J Psychiatr Res 1985;19:57-64.
- U.S. Public Health
Service, The Surgeon General's Call To Action To Prevent Suicide.
Washington, DC: 1999.
- World Health
Organization. World Health Report 2001, Mental Health: New Understanding,
New Hope. Geneva: 2001.
|
